Pneumococcal disease is responsible for thousands of deaths every year. While preventive immunisations exist, not all patients can access them.
To address this gap, GAfPA hosted “Communicating the Science of Pneumococcal Disease Prevention More Effectively to Policymakers” alongside the International Society of Pneumonia and Pneumococcal Diseases meeting in Copenhagen.
Effective Communication is Key
The day-long workshop brought together medical and scientific leaders from around the world to refine their communication skills with policymakers and media.
The agenda included multiple interactive sessions on:
Attendees also participated in breakout sessions where they practiced persuading policymakers and interviewing with the media.
This training followed similar programs about RSV hosted in Lisbon and Rome. The series of workshops equipped attendees with the communication tools they need to advocate for access to prevention.
About Pneumococcal Disease
Pneumococcal disease is any illness caused by the bacteria pneumococcus. While the disease can cause mild symptoms like a sinus or ear infection, it can also cause serious complications, including pneumonia, meningitis and infections of the bloodstream.
While anyone is at risk, it can be particularly harmful to young children and older adults.
Pneumococcal disease can levy a heavy burden on patients and their caregivers. Patients with severe disease often end up in the hospital, leaving them with unexpected out-of-pocket costs. Recovery can mean extended periods of time off work, which can result in lost wages.
That’s why effectively communicating information about prevention and advocating for access to immunisations is critical. When policymakers have the information they need, they can make smart policy decisions that will lead to a healthier society.
Learn more about pneumococcal disease and RSV from GAfPA’s Respiratory Health initiative.